Evidence-based clinical practice guidelines for nephrotic syndrome 2014.
Evidence-based clinical practice guidelines for nephrotic syndrome 2014.
复制标题
DOI：
10.1007/s10157-015-1216-x
复制
发表时间：
2016-06
影响因子：
2.3
通讯作者：
Matsuo S
中科院分区：
文献类型：
--
作者：
Nishi S;Ubara Y;Utsunomiya Y;Okada K;Obata Y;Kai H;Kiyomoto H;Goto S;Konta T;Sasatomi Y;Sato Y;Nishino T;Tsuruya K;Furuichi K;Hoshino J;Watanabe Y;Kimura K;Matsuo S
在日本，关于肾病综合征(NS)的原始研究最初是由厚生劳动省(MHLW)肾病研究小组进行的。1973年MHLW NS研究小组报告了NS的第一个定义。随后，治疗效果的标准在1974年被记录在案。基于HLWM NS研究组持续的临床研究和社会行动，难治性NS的定义于1999年确定。已经接受包括类固醇在内的各种药物治疗的NS，在开始治疗后6个月内没有达到完全或不完全缓解，称为难治性NS。2002年，HLWM NS研究小组发表了《难治性肾病综合征(成人病例)指南》。这是日本第一个NS指南。因此，该组织和日本肾脏病学会(JSN)在2011年发布了第二份指南《肾病综合征指南》。目前，卫生部和JSN的合作工作组的目标是在2014年发布和制定第三个NS准则。新指南旨在根据循证医学在临床环境中提供建议，并根据医疗信息网络分发服务(Minds)临床实践指南的出版政策使用临床问题描述(CQS)。
In Japan, original researches on nephrotic syndrome (NS) were initially performed by the Ministry of Health, Labour and Welfare (MHLW) NS research group. The first definition of NS was reported by the MHLW NS research group in 1973. Subsequently, the criteria for treatment effects were documented in 1974. Based on the continued clinical researches and social actions by the HLWM NS research group, the definition of refractory NS was determined in 1999. NS already treated with various agents, including steroids, that does not reach complete or incomplete remission within 6 months after the initiation of treatment is known as refractory NS. In 2002, the HLWM NS research group published the ‘‘Guideline for Refractory Nephrotic Syndrome (Adult Cases).’’This was the first NS guideline in Japan. Consequently, this group and the Japanese Society of Nephrology (JSN) published the second guideline,‘‘Guideline for Nephrotic Syndrome,’’in 2011. Currently, the collaborative working group of the MHLW and JSN aimed to publish and establish the third NS guideline in 2014. The new guideline aims to provide recommendations in clinical settings according to evidence-based medicine and it uses a description of clinical questions (CQs) according to the policy of publication for the clinical practice guidelines of the Medical Information Network Distribution Service (MINDS).